ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dilated Cardiomyopathy Therapeutic Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-20J14468
Home | Market Reports | Health| Health Conditions| Heart & Hypertension
Global Dilated Cardiomyopathy Therapeutic Market Research Report 2023
BUY CHAPTERS

Global Dilated Cardiomyopathy Therapeutic Market Insights, Forecast to 2030

Code: QYRE-Auto-20J14468
Report
December 2024
Pages:106
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Array BioPharma Inc
Astrazeneca plc
Celladon Corporation
GlaxoSmithKline PLC
Janssen Pharmaceuticals, Inc. (J&J)
Merck& Co. Inc
Novartis International AG
Pfizer Inc
Sanofi
Teva Pharmaceutical Industries Ltd
Vericel Corporation

Dilated Cardiomyopathy Therapeutic Market Size

The global Dilated Cardiomyopathy Therapeutic market is projected to grow from US$ 333.3 million in 2024 to US$ 418.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.9% during the forecast period.

Dilated Cardiomyopathy Therapeutic Market

Dilated Cardiomyopathy Therapeutic Market

Dilated cardiomyopathy (DCM) is characterized by LV (left ventricular) or biventricular systolic dysfunction and dilation, not explained by abnormal loading conditions or coronary artery disease.
Market Analysis and Insights: Global Dilated Cardiomyopathy Therapeutic Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Dilated Cardiomyopathy Therapeutic market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Dilated Cardiomyopathy Therapeutic, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Dilated Cardiomyopathy Therapeutic, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Dilated Cardiomyopathy Therapeutic revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Dilated Cardiomyopathy Therapeutic market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Dilated Cardiomyopathy Therapeutic revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Dilated Cardiomyopathy Therapeutic Market Report

Report Metric Details
Report Name Dilated Cardiomyopathy Therapeutic Market
Accounted market size in 2024 US$ 333.3 million
Forecasted market size in 2030 US$ 418.1 million
CAGR 3.9
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • Aldosterone antagonists
  • Angiotensin-converting enzyme (ACE) inhibitors
  • Angiotensin II receptor blockers (ARBs)
  • Beta-blockers
Segment by Application
  • Hospitals
  • Academic Institutions
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Array BioPharma, Inc., AstraZeneca plc., Celladon Corporation, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc. (J&J), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Vericel Corporation
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Dilated Cardiomyopathy Therapeutic in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Dilated Cardiomyopathy Therapeutic companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dilated Cardiomyopathy Therapeutic revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Dilated Cardiomyopathy Therapeutic Market growing?

Ans: The Dilated Cardiomyopathy Therapeutic Market witnessing a CAGR of 3.9 during the forecast period 2025-2030.

What is the Dilated Cardiomyopathy Therapeutic Market size in 2030?

Ans: The Dilated Cardiomyopathy Therapeutic Market size in 2030 will be US$ 418.1 million.

Who are the main players in the Dilated Cardiomyopathy Therapeutic Market report?

Ans: The main players in the Dilated Cardiomyopathy Therapeutic Market are Array BioPharma, Inc., AstraZeneca plc., Celladon Corporation, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc. (J&J), Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., Vericel Corporation

What are the Application segmentation covered in the Dilated Cardiomyopathy Therapeutic Market report?

Ans: The Applications covered in the Dilated Cardiomyopathy Therapeutic Market report are Hospitals, Academic Institutions

What are the Type segmentation covered in the Dilated Cardiomyopathy Therapeutic Market report?

Ans: The Types covered in the Dilated Cardiomyopathy Therapeutic Market report are Aldosterone antagonists, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor blockers (ARBs), Beta-blockers

Recommended Reports

Cardiovascular Therapies

Heart Disease Devices

Rare Cardiomyopathies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Aldosterone antagonists
1.2.3 Angiotensin-converting enzyme (ACE) inhibitors
1.2.4 Angiotensin II receptor blockers (ARBs)
1.2.5 Beta-blockers
1.3 Market by Application
1.3.1 Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Academic Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Dilated Cardiomyopathy Therapeutic Market Perspective (2019-2030)
2.2 Global Dilated Cardiomyopathy Therapeutic Growth Trends by Region
2.2.1 Dilated Cardiomyopathy Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Dilated Cardiomyopathy Therapeutic Historic Market Size by Region (2019-2024)
2.2.3 Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Region (2025-2030)
2.3 Dilated Cardiomyopathy Therapeutic Market Dynamics
2.3.1 Dilated Cardiomyopathy Therapeutic Industry Trends
2.3.2 Dilated Cardiomyopathy Therapeutic Market Drivers
2.3.3 Dilated Cardiomyopathy Therapeutic Market Challenges
2.3.4 Dilated Cardiomyopathy Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Dilated Cardiomyopathy Therapeutic by Players
3.1.1 Global Dilated Cardiomyopathy Therapeutic Revenue by Players (2019-2024)
3.1.2 Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Players (2019-2024)
3.2 Global Dilated Cardiomyopathy Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Dilated Cardiomyopathy Therapeutic, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Dilated Cardiomyopathy Therapeutic Market Concentration Ratio
3.4.1 Global Dilated Cardiomyopathy Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dilated Cardiomyopathy Therapeutic Revenue in 2023
3.5 Global Key Players of Dilated Cardiomyopathy Therapeutic Head office and Area Served
3.6 Global Key Players of Dilated Cardiomyopathy Therapeutic, Product and Application
3.7 Global Key Players of Dilated Cardiomyopathy Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Dilated Cardiomyopathy Therapeutic Breakdown Data by Type
4.1 Global Dilated Cardiomyopathy Therapeutic Historic Market Size by Type (2019-2024)
4.2 Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Type (2025-2030)
5 Dilated Cardiomyopathy Therapeutic Breakdown Data by Application
5.1 Global Dilated Cardiomyopathy Therapeutic Historic Market Size by Application (2019-2024)
5.2 Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Dilated Cardiomyopathy Therapeutic Market Size (2019-2030)
6.2 North America Dilated Cardiomyopathy Therapeutic Market Size by Type
6.2.1 North America Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024)
6.2.2 North America Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030)
6.2.3 North America Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
6.3 North America Dilated Cardiomyopathy Therapeutic Market Size by Application
6.3.1 North America Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024)
6.3.2 North America Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030)
6.3.3 North America Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
6.4 North America Dilated Cardiomyopathy Therapeutic Market Size by Country
6.4.1 North America Dilated Cardiomyopathy Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Dilated Cardiomyopathy Therapeutic Market Size by Country (2019-2024)
6.4.3 North America Dilated Cardiomyopathy Therapeutic Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Dilated Cardiomyopathy Therapeutic Market Size (2019-2030)
7.2 Europe Dilated Cardiomyopathy Therapeutic Market Size by Type
7.2.1 Europe Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024)
7.2.2 Europe Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030)
7.2.3 Europe Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
7.3 Europe Dilated Cardiomyopathy Therapeutic Market Size by Application
7.3.1 Europe Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024)
7.3.2 Europe Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030)
7.3.3 Europe Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
7.4 Europe Dilated Cardiomyopathy Therapeutic Market Size by Country
7.4.1 Europe Dilated Cardiomyopathy Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Dilated Cardiomyopathy Therapeutic Market Size by Country (2019-2024)
7.4.3 Europe Dilated Cardiomyopathy Therapeutic Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Dilated Cardiomyopathy Therapeutic Market Size (2019-2030)
8.2 China Dilated Cardiomyopathy Therapeutic Market Size by Type
8.2.1 China Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024)
8.2.2 China Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030)
8.2.3 China Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
8.3 China Dilated Cardiomyopathy Therapeutic Market Size by Application
8.3.1 China Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024)
8.3.2 China Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030)
8.3.3 China Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Dilated Cardiomyopathy Therapeutic Market Size (2019-2030)
9.2 Asia Dilated Cardiomyopathy Therapeutic Market Size by Type
9.2.1 Asia Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024)
9.2.2 Asia Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030)
9.2.3 Asia Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
9.3 Asia Dilated Cardiomyopathy Therapeutic Market Size by Application
9.3.1 Asia Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024)
9.3.2 Asia Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030)
9.3.3 Asia Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
9.4 Asia Dilated Cardiomyopathy Therapeutic Market Size by Region
9.4.1 Asia Dilated Cardiomyopathy Therapeutic Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Dilated Cardiomyopathy Therapeutic Market Size by Region (2019-2024)
9.4.3 Asia Dilated Cardiomyopathy Therapeutic Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type
10.2.1 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application
10.3.1 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country
10.4.1 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Array BioPharma, Inc.
11.1.1 Array BioPharma, Inc. Company Details
11.1.2 Array BioPharma, Inc. Business Overview
11.1.3 Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Introduction
11.1.4 Array BioPharma, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.1.5 Array BioPharma, Inc. Recent Developments
11.2 AstraZeneca plc.
11.2.1 AstraZeneca plc. Company Details
11.2.2 AstraZeneca plc. Business Overview
11.2.3 AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Introduction
11.2.4 AstraZeneca plc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.2.5 AstraZeneca plc. Recent Developments
11.3 Celladon Corporation
11.3.1 Celladon Corporation Company Details
11.3.2 Celladon Corporation Business Overview
11.3.3 Celladon Corporation Dilated Cardiomyopathy Therapeutic Introduction
11.3.4 Celladon Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.3.5 Celladon Corporation Recent Developments
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Details
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Introduction
11.4.4 GlaxoSmithKline plc Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.4.5 GlaxoSmithKline plc Recent Developments
11.5 Janssen Pharmaceuticals, Inc. (J&J)
11.5.1 Janssen Pharmaceuticals, Inc. (J&J) Company Details
11.5.2 Janssen Pharmaceuticals, Inc. (J&J) Business Overview
11.5.3 Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Introduction
11.5.4 Janssen Pharmaceuticals, Inc. (J&J) Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.5.5 Janssen Pharmaceuticals, Inc. (J&J) Recent Developments
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Introduction
11.6.4 Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.6.5 Merck & Co., Inc. Recent Developments
11.7 Novartis International AG
11.7.1 Novartis International AG Company Details
11.7.2 Novartis International AG Business Overview
11.7.3 Novartis International AG Dilated Cardiomyopathy Therapeutic Introduction
11.7.4 Novartis International AG Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.7.5 Novartis International AG Recent Developments
11.8 Pfizer, Inc.
11.8.1 Pfizer, Inc. Company Details
11.8.2 Pfizer, Inc. Business Overview
11.8.3 Pfizer, Inc. Dilated Cardiomyopathy Therapeutic Introduction
11.8.4 Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.8.5 Pfizer, Inc. Recent Developments
11.9 Sanofi S.A.
11.9.1 Sanofi S.A. Company Details
11.9.2 Sanofi S.A. Business Overview
11.9.3 Sanofi S.A. Dilated Cardiomyopathy Therapeutic Introduction
11.9.4 Sanofi S.A. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.9.5 Sanofi S.A. Recent Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Details
11.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Introduction
11.10.4 Teva Pharmaceutical Industries Ltd. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.10.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.11 Vericel Corporation
11.11.1 Vericel Corporation Company Details
11.11.2 Vericel Corporation Business Overview
11.11.3 Vericel Corporation Dilated Cardiomyopathy Therapeutic Introduction
11.11.4 Vericel Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
11.11.5 Vericel Corporation Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Array BioPharma Inc
Astrazeneca plc
Celladon Corporation
GlaxoSmithKline PLC
Janssen Pharmaceuticals, Inc. (J&J)
Merck& Co. Inc
Novartis International AG
Pfizer Inc
Sanofi
Teva Pharmaceutical Industries Ltd
Vericel Corporation
List of Tables
    Table 1. Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Aldosterone antagonists
    Table 3. Key Players of Angiotensin-converting enzyme (ACE) inhibitors
    Table 4. Key Players of Angiotensin II receptor blockers (ARBs)
    Table 5. Key Players of Beta-blockers
    Table 6. Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Dilated Cardiomyopathy Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Dilated Cardiomyopathy Therapeutic Market Share by Region (2019-2024)
    Table 10. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Dilated Cardiomyopathy Therapeutic Market Share by Region (2025-2030)
    Table 12. Dilated Cardiomyopathy Therapeutic Market Trends
    Table 13. Dilated Cardiomyopathy Therapeutic Market Drivers
    Table 14. Dilated Cardiomyopathy Therapeutic Market Challenges
    Table 15. Dilated Cardiomyopathy Therapeutic Market Restraints
    Table 16. Global Dilated Cardiomyopathy Therapeutic Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Dilated Cardiomyopathy Therapeutic Revenue Share by Players (2019-2024)
    Table 18. Global Top Dilated Cardiomyopathy Therapeutic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dilated Cardiomyopathy Therapeutic as of 2023)
    Table 19. Global Dilated Cardiomyopathy Therapeutic Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Dilated Cardiomyopathy Therapeutic Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Dilated Cardiomyopathy Therapeutic, Headquarters and Area Served
    Table 22. Global Key Players of Dilated Cardiomyopathy Therapeutic, Product and Application
    Table 23. Global Key Players of Dilated Cardiomyopathy Therapeutic, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Type (2019-2024)
    Table 27. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Dilated Cardiomyopathy Therapeutic Revenue Market Share by Type (2025-2030)
    Table 29. Global Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Dilated Cardiomyopathy Therapeutic Revenue Share by Application (2019-2024)
    Table 31. Global Dilated Cardiomyopathy Therapeutic Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Dilated Cardiomyopathy Therapeutic Revenue Share by Application (2025-2030)
    Table 33. North America Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Dilated Cardiomyopathy Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Dilated Cardiomyopathy Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Dilated Cardiomyopathy Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Dilated Cardiomyopathy Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Dilated Cardiomyopathy Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Dilated Cardiomyopathy Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Dilated Cardiomyopathy Therapeutic Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Dilated Cardiomyopathy Therapeutic Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Dilated Cardiomyopathy Therapeutic Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Array BioPharma, Inc. Company Details
    Table 66. Array BioPharma, Inc. Business Overview
    Table 67. Array BioPharma, Inc. Dilated Cardiomyopathy Therapeutic Product
    Table 68. Array BioPharma, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 69. Array BioPharma, Inc. Recent Developments
    Table 70. AstraZeneca plc. Company Details
    Table 71. AstraZeneca plc. Business Overview
    Table 72. AstraZeneca plc. Dilated Cardiomyopathy Therapeutic Product
    Table 73. AstraZeneca plc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 74. AstraZeneca plc. Recent Developments
    Table 75. Celladon Corporation Company Details
    Table 76. Celladon Corporation Business Overview
    Table 77. Celladon Corporation Dilated Cardiomyopathy Therapeutic Product
    Table 78. Celladon Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 79. Celladon Corporation Recent Developments
    Table 80. GlaxoSmithKline plc Company Details
    Table 81. GlaxoSmithKline plc Business Overview
    Table 82. GlaxoSmithKline plc Dilated Cardiomyopathy Therapeutic Product
    Table 83. GlaxoSmithKline plc Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 84. GlaxoSmithKline plc Recent Developments
    Table 85. Janssen Pharmaceuticals, Inc. (J&J) Company Details
    Table 86. Janssen Pharmaceuticals, Inc. (J&J) Business Overview
    Table 87. Janssen Pharmaceuticals, Inc. (J&J) Dilated Cardiomyopathy Therapeutic Product
    Table 88. Janssen Pharmaceuticals, Inc. (J&J) Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 89. Janssen Pharmaceuticals, Inc. (J&J) Recent Developments
    Table 90. Merck & Co., Inc. Company Details
    Table 91. Merck & Co., Inc. Business Overview
    Table 92. Merck & Co., Inc. Dilated Cardiomyopathy Therapeutic Product
    Table 93. Merck & Co., Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 94. Merck & Co., Inc. Recent Developments
    Table 95. Novartis International AG Company Details
    Table 96. Novartis International AG Business Overview
    Table 97. Novartis International AG Dilated Cardiomyopathy Therapeutic Product
    Table 98. Novartis International AG Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 99. Novartis International AG Recent Developments
    Table 100. Pfizer, Inc. Company Details
    Table 101. Pfizer, Inc. Business Overview
    Table 102. Pfizer, Inc. Dilated Cardiomyopathy Therapeutic Product
    Table 103. Pfizer, Inc. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 104. Pfizer, Inc. Recent Developments
    Table 105. Sanofi S.A. Company Details
    Table 106. Sanofi S.A. Business Overview
    Table 107. Sanofi S.A. Dilated Cardiomyopathy Therapeutic Product
    Table 108. Sanofi S.A. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 109. Sanofi S.A. Recent Developments
    Table 110. Teva Pharmaceutical Industries Ltd. Company Details
    Table 111. Teva Pharmaceutical Industries Ltd. Business Overview
    Table 112. Teva Pharmaceutical Industries Ltd. Dilated Cardiomyopathy Therapeutic Product
    Table 113. Teva Pharmaceutical Industries Ltd. Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 114. Teva Pharmaceutical Industries Ltd. Recent Developments
    Table 115. Vericel Corporation Company Details
    Table 116. Vericel Corporation Business Overview
    Table 117. Vericel Corporation Dilated Cardiomyopathy Therapeutic Product
    Table 118. Vericel Corporation Revenue in Dilated Cardiomyopathy Therapeutic Business (2019-2024) & (US$ Million)
    Table 119. Vericel Corporation Recent Developments
    Table 120. Research Programs/Design for This Report
    Table 121. Key Data Information from Secondary Sources
    Table 122. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Dilated Cardiomyopathy Therapeutic Market Share by Type: 2023 VS 2030
    Figure 3. Aldosterone antagonists Features
    Figure 4. Angiotensin-converting enzyme (ACE) inhibitors Features
    Figure 5. Angiotensin II receptor blockers (ARBs) Features
    Figure 6. Beta-blockers Features
    Figure 7. Global Dilated Cardiomyopathy Therapeutic Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Dilated Cardiomyopathy Therapeutic Market Share by Application: 2023 VS 2030
    Figure 9. Hospitals Case Studies
    Figure 10. Academic Institutions Case Studies
    Figure 11. Dilated Cardiomyopathy Therapeutic Report Years Considered
    Figure 12. Global Dilated Cardiomyopathy Therapeutic Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Dilated Cardiomyopathy Therapeutic Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Dilated Cardiomyopathy Therapeutic Market Share by Region: 2023 VS 2030
    Figure 15. Global Dilated Cardiomyopathy Therapeutic Market Share by Players in 2023
    Figure 16. Global Top Dilated Cardiomyopathy Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dilated Cardiomyopathy Therapeutic as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Dilated Cardiomyopathy Therapeutic Revenue in 2023
    Figure 18. North America Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
    Figure 20. North America Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
    Figure 21. North America Dilated Cardiomyopathy Therapeutic Market Share by Country (2019-2030)
    Figure 22. United States Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Dilated Cardiomyopathy Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 25. Europe Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
    Figure 26. Europe Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
    Figure 27. Europe Dilated Cardiomyopathy Therapeutic Market Share by Country (2019-2030)
    Figure 28. Germany Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. France Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. U.K. Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Italy Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Russia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Nordic Countries Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. China Dilated Cardiomyopathy Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 35. China Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
    Figure 36. China Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
    Figure 37. Asia Dilated Cardiomyopathy Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. Asia Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
    Figure 39. Asia Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
    Figure 40. Asia Dilated Cardiomyopathy Therapeutic Market Share by Region (2019-2030)
    Figure 41. Japan Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. South Korea Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. China Taiwan Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. India Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Australia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Size YoY (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Share by Type (2019-2030)
    Figure 49. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Share by Application (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Dilated Cardiomyopathy Therapeutic Market Share by Country (2019-2030)
    Figure 51. Brazil Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Mexico Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Turkey Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Saudi Arabia Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Israel Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. GCC Countries Dilated Cardiomyopathy Therapeutic Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Array BioPharma, Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 58. AstraZeneca plc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 59. Celladon Corporation Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 60. GlaxoSmithKline plc Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 61. Janssen Pharmaceuticals, Inc. (J&J) Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 62. Merck & Co., Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 63. Novartis International AG Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 64. Pfizer, Inc. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 65. Sanofi S.A. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 66. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 67. Vericel Corporation Revenue Growth Rate in Dilated Cardiomyopathy Therapeutic Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Dilated Cardiomyopathy Therapeutics Market Insights Forecast to 2030
Global Cardiomyopathy Medication Market Insights Forecast to 2030
Global Left Ventricular Dysfunction Drug Market Research Report 2025
Global Cardiomyopathy Devices Market Research Report 2025
Global Canine Dilated Cardiomyopathy Drug Market Insights Forecast to 2030
Global Cardiometabolic Drug Market Insights Forecast to 2030
Global Ventricular Tachycardia Treatment Market Insights Forecast to 2030
Global Heart Failure Therapeutics Market Research Report 2024
Restrictive Cardiomyopathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Ischemic Cardiomyopathy Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Renal Fibrosis Treatment Market Insights Forecast to 2030
Global Cardiac Contractility Modulation CCM Market Research Report 2024
Global Ventricular Restoration Systems Market Research Report 2024
Global Cardiac Disease Stem Cell Therapy Market Research Report 2024
Global Neurologic Disorders Therapeutics Market Insights Forecast to 2030
Chronic Heart Failure Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Implantable Cardiac Rhythm Management Device Market Insights Forecast to 2030
Global Valvular Heart Disease Treatment Market Insights Forecast to 2030
Global Neurodegenerative Disease Market Insights Forecast to 2030
Global Cardiology Stem Cells Market Research Report 2024

RELATED REPORTS

Global Adult Artificial Heart Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32W16534
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33A16598
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Inotropic Drug Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-23Y16200
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Retrograde Cardioplegia Cannula Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29Z16493
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions